Diamyd Medical CEO proposed as new Chairman for Cellaviva AB

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that its CEO, Anders Essen-Möller is proposed as new Chairman of the Board of Cellaviva AB at Cellaviva’s Annual General Meeting, February 18, 2016. Diamyd Medical is the largest shareholder of Cellaviva AB, Sweden’s first biobank for family saving and research on stem cells from the umbilical cord.“The umbilical cord contains stem cells that can be differentiated into several of the various cells of the body. This technology is one of today’s fastest growing medical research areas and Diamyd Medical’s commitment